Orthofix Medical Inc. (OFIX) EPS Estimated At $0.40

October 2, 2018 - By Peter Kolinski

Orthofix Medical Inc. (NASDAQ:OFIX) LogoInvestors sentiment decreased to 1.14 in Q2 2018. Its down 0.39, from 1.53 in 2018Q1. It worsened, as 31 investors sold Orthofix Medical Inc. shares while 34 reduced holdings. 16 funds opened positions while 58 raised stakes. 16.15 million shares or 0.09% less from 16.17 million shares in 2018Q1 were reported.
Moreover, Kennedy has 0.12% invested in Orthofix Medical Inc. (NASDAQ:OFIX) for 112,194 shares. Gabelli Funds Ltd Company holds 289,396 shares or 0.1% of its portfolio. Amer Century invested in 0.01% or 150,194 shares. Tci Wealth Advsr has 0% invested in Orthofix Medical Inc. (NASDAQ:OFIX) for 14 shares. Deutsche Bancshares Ag reported 29,350 shares. Krensavage Asset Mngmt Limited Liability Co accumulated 300,049 shares. 665 were accumulated by Prelude Mngmt Limited Liability Corporation. Parkside Natl Bank And holds 17 shares or 0% of its portfolio. Balyasny Asset Mngmt Ltd Company stated it has 0% in Orthofix Medical Inc. (NASDAQ:OFIX). California State Teachers Retirement Sys reported 26,763 shares. Fort Washington Invest Advisors Incorporated Oh reported 0.18% stake. State Street owns 677,577 shares or 0% of their US portfolio. Acadian Asset Management Limited Liability Company holds 0.09% in Orthofix Medical Inc. (NASDAQ:OFIX) or 354,315 shares. Contravisory Management has invested 0.06% in Orthofix Medical Inc. (NASDAQ:OFIX). Alliancebernstein Lp reported 0% stake.

Since May 3, 2018, it had 1 buying transaction, and 7 sales for $5.14 million activity. $1.94M worth of stock was sold by FUJIKAWA RAYMOND on Wednesday, June 20. On Tuesday, June 19 the insider Bianchi Davide sold $885,720. $519,724 worth of Orthofix Medical Inc. (NASDAQ:OFIX) shares were bought by MATRICARIA RONALD A. 30,000 shares valued at $1.76M were sold by Finegan Michael on Monday, June 18. On Monday, July 2 NIEMANN BRADLEY V. sold $641,435 worth of Orthofix Medical Inc. (NASDAQ:OFIX) or 11,250 shares.

Analysts expect Orthofix Medical Inc. (NASDAQ:OFIX) to report $0.40 EPS on October, 29.They anticipate $0.02 EPS change or 4.76 % from last quarter’s $0.42 EPS. OFIX’s profit would be $7.56M giving it 35.63 P/E if the $0.40 EPS is correct. After having $0.42 EPS previously, Orthofix Medical Inc.’s analysts see -4.76 % EPS growth. The stock decreased 1.38% or $0.8 during the last trading session, reaching $57.01. About 99,694 shares traded. Orthofix Medical Inc. (NASDAQ:OFIX) has risen 6.89% since October 2, 2017 and is uptrending. It has underperformed by 8.73% the S&P500.

Orthofix International N.V., a medical device company, provides reconstructive and regenerative orthopedic and spine solutions to physicians worldwide. The company has market cap of $1.08 billion. It operates through four divisions: BioStim, Biologics, Extremity Fixation, and Spine Fixation. It has a 97.12 P/E ratio. The BioStim segment makes, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to improve fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spine fractures.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.